GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells - PubMed (original) (raw)
. 2008 May 16;369(4):1134-8.
doi: 10.1016/j.bbrc.2008.03.024. Epub 2008 Mar 17.
Affiliations
- PMID: 18346459
- DOI: 10.1016/j.bbrc.2008.03.024
GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells
Hanna Igarashi et al. Biochem Biophys Res Commun. 2008.
Abstract
Engagement of glucocorticoid-induced TNFR-related protein (GITR) enables the costimulation of both CD25(-)CD4(+) effector (Teff) and CD25(+)CD4(+) regulatory (Treg) cells; however, the effects of GITR-costimulation on Treg function remain controversial. In this study, we examined the effects of GITR ligand (GITRL) binding on the respective functions of CD4(+) T cells. GITRL-P815 transfectants efficiently augmented anti-CD3-induced proliferation and cytokine production by Teff cells. Proliferation and IL-10 production in Treg were also enhanced by GITRL transfectants when exogenous IL-2 and stronger CD3 stimulation was provided. Concomitant GITRL-costimulation of Teff and Treg converted the anergic state of Treg into a proliferating state, maintaining and augmenting their function. Thus, GITRL-costimulation augments both effector and regulatory functions of CD4(+) T cells. Our results suggest that highly activated and increased ratios of Treg reverse the immune-enhancing effects of GITRL-costimulation in Teff, which may be problematic for therapeutic applications using strong GITR agonists.
Similar articles
- Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
Nagayama Y, Hase W, Motoyoshi Y, Saitoh O, Sogawa R, Nakao K. Nagayama Y, et al. Oncol Rep. 2007 May;17(5):1269-73. Oncol Rep. 2007. PMID: 17390075 - Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
Xia G, He J, Zhang Z, Leventhal JR. Xia G, et al. Transplantation. 2006 Dec 27;82(12):1749-55. doi: 10.1097/01.tp.0000250731.44913.ee. Transplantation. 2006. PMID: 17198271 - GITR/GITRL: more than an effector T cell co-stimulatory system.
Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C. Nocentini G, et al. Eur J Immunol. 2007 May;37(5):1165-9. doi: 10.1002/eji.200636933. Eur J Immunol. 2007. PMID: 17407102 Review. - GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily.
Nocentini G, Riccardi C. Nocentini G, et al. Eur J Immunol. 2005 Apr;35(4):1016-22. doi: 10.1002/eji.200425818. Eur J Immunol. 2005. PMID: 15770698 Review.
Cited by
- Neurodegenerative diseases as proteinopathies-driven immune disorders.
Ciccocioppo F, Bologna G, Ercolino E, Pierdomenico L, Simeone P, Lanuti P, Pieragostino D, Del Boccio P, Marchisio M, Miscia S. Ciccocioppo F, et al. Neural Regen Res. 2020 May;15(5):850-856. doi: 10.4103/1673-5374.268971. Neural Regen Res. 2020. PMID: 31719246 Free PMC article. Review. - The Transcriptional Differences of Avian CD4+CD8+ Double-Positive T Cells and CD8+ T Cells From Peripheral Blood of ALV-J Infected Chickens Revealed by Smart-Seq2.
Dai M, Zhao L, Li Z, Li X, You B, Zhu S, Liao M. Dai M, et al. Front Cell Infect Microbiol. 2021 Nov 10;11:747094. doi: 10.3389/fcimb.2021.747094. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34858872 Free PMC article. - Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.
Placke T, Kopp HG, Salih HR. Placke T, et al. Clin Dev Immunol. 2010;2010:239083. doi: 10.1155/2010/239083. Epub 2010 Sep 26. Clin Dev Immunol. 2010. PMID: 20936139 Free PMC article. Review. - Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease.
Tomizawa R, Watanabe M, Inoue N, Takemura K, Hidaka Y, Akamizu T, Hayakawa K, Iwatani Y. Tomizawa R, et al. Clin Exp Immunol. 2011 Aug;165(2):141-7. doi: 10.1111/j.1365-2249.2011.04414.x. Epub 2011 May 19. Clin Exp Immunol. 2011. PMID: 21592113 Free PMC article. - Integrating costimulatory agonists to optimize immune-based cancer therapies.
Pardee AD, Wesa AK, Storkus WJ. Pardee AD, et al. Immunotherapy. 2009 Mar;1(2):249-64. doi: 10.2217/1750743X.1.2.249. Immunotherapy. 2009. PMID: 20046961 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials